Market Place
Sourcing Support
ACTG Links Abacavir Use To Higher Cardiovascular Risk In HIV Patients
23 Jul 2024 //
GLOBENEWSWIRE
Viatris Announces U.S. FDA Approval of a Paediatric Formulation of Abacavir
05 Sep 2023 //
PR NEWSWIRE
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
14 Jun 2022 //
EXPRESS PHARMA
ViiV seeks FDA approval for dispersible single tablet regimen with dolutegravir
05 Oct 2021 //
PHARMABIZ
ViiV seeks FDA approval for dispersible single tablet regimen with dolutegravir
05 Oct 2021 //
PHARMABIZ
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Apotex Research Private Limited On FDA Import Alert List
13 Apr 2018 //
FDA
Gilead says switching studies back new HIV therapy Biktarvy
06 Mar 2018 //
PMLIVE
Triumeq® (abacavir, dolutegravir, & lamivudine): VIIV Healthcare v. Mylan
17 Nov 2017 //
PATENT LITIGATION
Zydus Pharm`s Generic Abacavir;Lamivudine Receives Tentative Approval In US
08 Aug 2017 //
FDA
Zydus gets US FDA tentative marketing nod for abacavir & lamivudine tablets
08 Aug 2017 //
PHARMABIZ
Lupin launches generic HIV drug in US market
29 Mar 2017 //
ECONOMIC TIMES
Merck announces positve result from pivotal ph3 trial of Doravirine
16 Feb 2017 //
PHARMABIZ
Strides Shasun Receives FDA Approval for Abacavir Tablets
03 Nov 2016 //
BIOSPECTRUM
GSK execs, analysts talk up a turnaround as Q1 sales, profits beat estimates
28 Apr 2016 //
FIERCE PHARMA
ViiV Healthcare and Medicines Patent Pool extend the license of dolutegravir to all middle income countries
25 Apr 2016 //
PR NEWSWIRE
The top 20 drugs in 2020--worldwide sales
22 Feb 2016 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.